Editor
We read with great interest the article recently published by Barberi et al, in which the authors identified the presence of a positive swab for SARS-Cov-2 from the abdominal fluid in a 71-year-old COVID-19 positive woman who underwent a subtotal colectomy with terminal ileostomy. The authors stated that this was the first case in which the SARS-CoV-2 was identified within the abdominal cavity1. We would sincerely congratulate the authors for their interesting report, that however confirms the findings we have already reported in a previous publication2. We documented the presence of the SARS-CoV-2 in the peritoneal fluid of a positive 78-year-old male who underwent surgery for small bowel occlusion. The patient recovered well and was discharged in post-operative day 10. Interestingly, the nasal swab contained less SARS-Cov-2 RNA virus compared to the viral peritoneal fluid, which resulted comparable to the nasal swab when retested 10-fold diluted. The presence or not of the SARS-Cov-2 in the peritoneal fluid is a lively matter of debate in the recent COVID literature. In fact, to our knowledge there are only two reports in which SARS-CoV-2 was not detected on multiple samples of the peritoneum in COVID-19 positive operated patients3,4. No shareable messages were given in both reports. A potential SARS-CoV-2 positivity of the peritoneal fluid may dramatically influence the grade of exposure of the operating team to COVID-19-contaminated aerosol during laparoscopy or open surgery. For that reason, several precautions should be taken during an operation, including the use of full personal protective equipment, minimizing the number of medical personnel, evacuation of smoke with suction devices and, in case of laparoscopy, avoiding two-way pneumoperitoneum insufflators, and maintaining pneumoperitoneum pressure and ventilation at the lowest possible levels5,6. Furthermore, we believe that the use of devices capable of filtering released CO2 for aerosolized particles should be strongly recommended during laparoscopic surgery, where possible7. A multicenter study focusing on the sampling of peritoneal fluid in operated SARS-COV-2 patients would be mandatory in order to assess the real prevalence of the abdominal positivity of SARS-COV-2 RNA virus.
References
- 1. Barberis A, Rutigliani M, Belli F, Ciferri E, Mori M, Filauro M. SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic. Br J Surg 2020; 107: e376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Coccolini F, Tartaglia D, Puglisi A, Giordano C, Pistello M, Lodato M, Chiarugi M. SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients. Ann Surg 2020; 272: e240–e242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Romero-Velez G, Pereira X, Zenilman A, Camacho D. SARS-Cov-2 Was Not Found in the Peritoneal Fluid of an Asymptomatic Patient Undergoing Laparoscopic Appendectomy. Surg Laparosc Endosc Percutan Tech 2020. 10.1097/sle.0000000000000837. [DOI] [PMC free article] [PubMed]
- 4. Flemming S, Hankir M, Hering I, Meybohm P, Krone M, Weissbrich Bet al. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19. Br J Surg 2020; 107: e259–e260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Emile SH. Should we continue using laparoscopy amid the COVID -19 pandemic? Br J Surg 2020; 107: e240–e241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni L, Scandroglio Iet al. Surgery in COVID-19 patients: operational directives. World J Emerg Surg 2020; 15: 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Cicuttin E, Cobianchi L, Chiarugi M, Catena F, Coccolini F, Pietrabissa A. Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing. Surg Endosc 2020; 34: 2863–2865. [DOI] [PMC free article] [PubMed] [Google Scholar]